Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Support

This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.

Virtual Coffee Talk: Let's Talk About Best Practices for Neutropenia Management Today, With an Eye Toward Bridging Clinical Gaps Tomorrow!

Release Date: March 26, 2021
Expiration Date: September 26, 2021

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in the management of chemotherapy-induced neutropenia (CIN) for patients undergoing treatment for breast cancer. In this educational program, these experts discuss guideline recommendations, prophylactic strategies, biosimilars, and novel and emerging agents to treat real-life patients with breast cancer at risk for febrile neutropenia.

This educational activity is an archive of the live virtual symposium held on March 8, 2021.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational activity is directed toward medical oncologists who treat patients with breast cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Determine patient-, disease-, and treatment-specific characteristics used to stratify risk level for neutropenia and febrile neutropenia development during breast cancer treatment;
  • Assess the impact of CIN and adverse events associated with its management on patient outcomes and quality of life along the breast cancer care continuum;
  • Evaluate recently reported evidence on emerging single-agent and combination approaches for neutropenia management among patients with cancer; and
  • Integrate evolving CIN prevention and management strategies into real-world scenarios.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.


Douglas Blayney, MD
Douglas Blayney, MD
Professor of Medicine (Oncology)
Associate Division Chief of Medical Oncology
Stanford Health Care
Stanford, CA

Disclosures: Grant/Research Support: BeyondSpring Pharmaceuticals.


Gary Lyman, MD, MPH (Biostatistics), FASCO, FACP, FRCP
Gary Lyman, MD, MPH (Biostatistics), FASCO, FACP, FRCP
Professor, Public Health Sciences and Clinical Research Divisions,
Fred Hutchinson Cancer Research Center
Senior Lead, Healthcare Quality and Policy, Hutchinson Institute for Cancer Outcomes Research Professor of Medicine, Public Health and Pharmacy,
University of Washington School of Medicine
Seattle, WA

Disclosures: Grant/Research Support: Amgen to institution; Consultant: BeyondSpring Pharmaceuticals, G1 Therapeutics, Merck, Samsung, Teva Pharmaceuticals.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By